(19)
(11) EP 3 508 486 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.05.2023 Bulletin 2023/19

(45) Mention of the grant of the patent:
09.11.2022 Bulletin 2022/45

(21) Application number: 17845306.4

(22) Date of filing: 24.08.2017
(51) International Patent Classification (IPC): 
C07D 417/04(2006.01)
A61P 35/00(2006.01)
A61K 31/427(2006.01)
A61P 35/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/427; A61P 35/00; A61P 35/02; C07D 417/04
(86) International application number:
PCT/CN2017/098883
(87) International publication number:
WO 2018/041004 (08.03.2018 Gazette 2018/10)

(54)

ARYL-2,2'-TANDEM BISTHIAZOLE COMPOUND AND PREPARATION METHOD AND USE THEREOF

ARYL-2,2'-TANDEM-BISTHIAZOL-VERBINDUNG SOWIE HERSTELLUNGSVERFAHREN UND VERWENDUNG DAVON

COMPOSÉ DE BISTHIAZOLE ARYL -2,2'-TANDEM, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 31.08.2016 CN 201610786392

(43) Date of publication of application:
10.07.2019 Bulletin 2019/28

(73) Proprietor: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Zhangjiang, Pudong Shanghai 201203 (CN)

(72) Inventors:
  • NAN, Fajun
    Shanghai 201203 (CN)
  • LI, Jia
    Shanghai 201203 (CN)
  • DING, Jian
    Shanghai 201203 (CN)
  • GENG, Meiyu
    Shanghai 201203 (CN)
  • ZHANG, Yangming
    Shanghai 201203 (CN)
  • CHEN, Yi
    Shanghai 201203 (CN)
  • ZHOU, Yubo
    Shanghai 201203 (CN)
  • GONG, Chaojun
    Shanghai 201203 (CN)
  • SU, Mingbo
    Shanghai 201203 (CN)
  • GAO, Anhui
    Shanghai 201203 (CN)

(74) Representative: Keenway Patentanwälte Neumann Heine Taruttis 
PartG mbB Postfach 10 33 63
40024 Düsseldorf
40024 Düsseldorf (DE)


(56) References cited: : 
EP-A1- 2 708 534
CN-A- 102 775 368
WO-A1-2011/106632
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).